[1]
Lichtenfels, M. et al. 2026. Innovative platform for chemoresistance: advancing functional precision medicine in breast cancer. Mastology. 35, suppl.1 (Feb. 2026). DOI:https://doi.org/10.29289/259453942025V35S1006.